Keywords: oxford, biomedica, sees, promise, metxia, uk, firm

Oxford BioMedica sees promise with MetXia

Article | 09 November 2000

Print This

UK firm Oxford BioMedica says that its oncology product MetXia (aplatform gene technology used to increase tumor cell death via ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in